Home › Forums › Main Forum › Media & News › HCV New Drugs Blogspot
- This topic has 175 replies, 27 voices, and was last updated 8 years, 1 month ago by mgalbrai.
-
AuthorPosts
-
11 June 2016 at 7:48 pm #18919
This is hell on a phone…
Drug Rationing Plays Russian Roulette With Patients’ Lives
http://hepatitiscnewdrugs.blogspot.com/2016/06/drug-rationing-plays-russian-roulette.html?m=12,436 patients with hepatitis C in one Alabama ER since implementing widespread testing in 2013
http://hepatitiscnewdrugs.blogspot.com/2016/06/2436-patients-with-hepatitis-c-in-one.html?m=1Survival rates rise with new hepatitis C treatments
http://hepatitiscnewdrugs.blogspot.com/2016/06/survival-rates-rise-with-new-hepatitis.html?m=1****4 Week Tx*****
Regulus Reports Positive Data/Phase II studies of RG-101 for the treatment of Hepatitis C
http://hepatitiscnewdrugs.blogspot.com/2016/06/regulus-reports-positive-dataphase-ii.html?m=1Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs
http://hepatitiscnewdrugs.blogspot.com/2016/05/foretelling-toxicity-fda-researchers.html?m=1FDA warns against fake Hepatitis C medicines
http://hepatitiscnewdrugs.blogspot.com/2016/05/fda-warns-against-fake-hepatitis-c.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2415 June 2016 at 8:58 am #19090Outcomes in patients with chronic Hep C treated with different anti-viral regimens
http://hepatitiscnewdrugs.blogspot.com/2016/06/outcomes-in-patients-with-chronic-hep-c.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2416 June 2016 at 10:26 pm #19244Making Hepatitis C A Rare Disease In The United States
http://hepatitiscnewdrugs.blogspot.ro/2016/06/making-hepatitis-c-rare-disease-in.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2423 June 2016 at 3:12 am #19790A new non-DAA about to commence Phase 1 trials. Looks like it may have potential for ‘difficult to treat’ cases if proven.
http://hepatitiscnewdrugs.blogspot.com.au/2016/06/enanta-initiates-proof-of-concept-study.html
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
23 June 2016 at 3:37 am #19792mgalbrai wrote:Outcomes in patients with chronic Hep C treated with different anti-viral regimens
http://hepatitiscnewdrugs.blogspot.com/2016/06/outcomes-in-patients-with-chronic-hep-c.html?m=1
“Interferon- and ribavirin-containing regimens negatively impact patients’ experience. ”
They can pop that in BOLD!25 June 2016 at 11:59 pm #19946Now that we have the hepatitis C virus on the run, can a universal cure be attained?
http://hepatitiscnewdrugs.blogspot.com/2016/06/now-that-we-have-hepatitis-c-virus-on.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2426 June 2016 at 3:22 am #19947Thanks Mike. they had a good list of references, but were missing an important one. I added a highlight from latest Liver International journal.
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
26 June 2016 at 3:42 am #19948mgalbrai wrote:http://hepatitiscnewdrugs.blogspot.com/2016/06/now-that-we-have-hepatitis-c-virus-on.html?m=1
Ty Mike, many interesting studies to read plus
some good coffee news p5Setiawan and colleagues[16] evaluated the protective effect of coffee drinking in black, Native Hawaiian, Japanese American, Latino, and white patients with chronic liver diseases. Regular coffee intake was associated with reduced risks for NAFLD-related progression in a dose-dependent manner. For example, compared with non–coffee drinkers, those who reported drinking two to three cups and four or more cups of coffee per day had a 14% and a 34% reduction, respectively, in the risk for NAFLD-related disease. High consumption (four or more cups per day of regular coffee) was associated with a reduced risk for HCV-related chronic liver disease.[/I]
gt 1a VL 6m
F2/3 FibroScan – 9KPa in 2011 and 7KPa in 2015
sof/dac 10 December for 12 weeks
pre tx alt 85 ast 51
4 wk alt 34 ast 31 UND <35
8 wk alt 29 ast 32 UND <15
12wk alt 25 ast 25 EOT 3.3.16
SVR24 UND KPa5.3 F0 in normal range
I am well
.forever grateful to fixhepc8 July 2016 at 1:46 am #20677HCV Guidelines Update: Reflect Recent Approval of Epclusa (Sofosbuvir/Velpatasvir)
http://hepatitiscnewdrugs.blogspot.com/2016/07/hcv-guidelines-update-reflect-recent.html?m=1
Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially For Genotypes 2 and 3
http://hepatitiscnewdrugs.blogspot.com/2016/07/velpatasvirsofosbuvir-makes-hcv.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 248 July 2016 at 10:07 pm #20724Gilead’s Epclusa® – European Commission Grants Marketing Authorization
http://hepatitiscnewdrugs.blogspot.com/2016/07/gileads-epclusa-european-commission.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2411 July 2016 at 7:59 pm #20823Epclusa among hepatitis drugs that are medical miracles of the 21st century
http://hepatitiscnewdrugs.blogspot.com/2016/07/epclusa-among-hepatitis-drugs-that-are.html?m=1
Hazel Heal!!!
http://hepatitiscnewdrugs.blogspot.com/2016/07/listen-hep-c-buyers-club_11.html?m=1
Watch – New Opportunities and Challenges in Hepatitis C
http://hepatitiscnewdrugs.blogspot.com/2016/07/watch-new-opportunities-and-challenges.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2412 July 2016 at 7:07 pm #20871Generic Medications for Hepatitis C
http://hepatitiscnewdrugs.blogspot.com/2016/07/generic-medications-for-hepatitis-c.html?m=1
Hmmmmm…
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2417 July 2016 at 8:39 pm #21010Treatment of Chronic Hepatitis C in the Aged – Does It Impact Life Expectancy? A Decision Analysis
http://hepatitiscnewdrugs.blogspot.com/2016/07/treatment-of-chronic-hepatitis-c-in.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2429 July 2016 at 2:26 am #21564David Bernstein: Managing Risk Factors in Hepatitis C
http://hepatitiscnewdrugs.blogspot.com/2016/07/treating-liver-disease-beyond-hepatitis.html?m=1
UK health service under fire over access to hepatitis C drugs
http://hepatitiscnewdrugs.blogspot.com/2016/07/uk-health-service-under-fire-over.html?m=1
New medication shows promise against liver fibrosis in animal studies
http://hepatitiscnewdrugs.blogspot.com/2016/07/new-medication-shows-promise-against.html?m=1
http://hepatitiscnewdrugs.blogspot.com/2016/07/adding-ribavirin-to-newer-daa-regimens.html?m=1
Discovery of new Hepatitis C Virus mechanism
http://hepatitiscnewdrugs.blogspot.com/2016/07/discovery-of-new-hepatitis-c-virus.html?m=1
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 249 August 2016 at 11:10 pm #22025Elbasvir-grazoprevir works effectively against HCV despite current drug use
https://hepatitiscnewdrugs.blogspot.com/2016/08/elbasvir-grazoprevir-works-effectively.html‘Tax haven’ Ireland accused of helping US firm treble untaxed profits
https://hepatitiscnewdrugs.blogspot.com/2016/08/tax-haven-ireland-accused-of-helping-us.htmlWhy are hepatitis C patients treated differently by NHS England?
https://hepatitiscnewdrugs.blogspot.com/2016/08/why-are-hepatitis-c-patients-treated.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24 -
AuthorPosts
- You must be logged in to reply to this topic.